Cempra Holdings (NASDAQ:CEMP)

CAPS Rating: 5 out of 5 92.88

Caps

How do you think CEMP will perform against the market?

Add Stock to CAPS Watchlist

All Players

65 Outperform
3 Underperform
 

All-Star Players

11 Outperform
1 Underperform
 

Wall Street

4 Outperform
0 Underperform
 

Top CEMP Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

tsaifool (75.18)
Submitted February 21, 2014

two drugs in development, solithromycin will address increasing resistance with STDs like gonorrhea, Fusidic acid will finally come from Europe and be used in US, both have good prospects. Expect stock to be bought out be a larger firm with… More

Top Bear Pitch

There are no pitches that meet the Top Bear criteria. Explain

If this upsets you, start recommending pitches below!

CEMP VS S&P 500 (SPY)

Fools bullish on CEMP are also bullish on:

Recent Community Commentary

Read the most recent pitches from players about CEMP.

Recs

0
Member Avatar TMFTypeoh (93.94) Submitted: 10/23/2017 1:20:22 PM : Outperform Start Price: $2.73 CEMP Score: -25.50

Next-generation antibiotics play. Approaching this as a basket.

Recs

0
Member Avatar msj1819 (< 20) Submitted: 2/26/2016 1:53:23 PM : Outperform Start Price: $18.24 CEMP Score: -132.86

FDA Approval for signature drug Solithromycin (with Fast Track and Qualified Infectious Disease Product status) for Community Acquired Bacterial Pneumonia (among other potential uses, including some prevalent STDs) is anticipated within 2016 and company is getting poised to launch quickly upon approval. CEMP says they have adequate funding to get through at least the first quarter of 2017 which would include the launch start-up costs and additional clinical trials for this and another pipeline drug, Taksta.

Recs

0
Member Avatar cptsintl (36.03) Submitted: 2/22/2015 4:51:13 PM : Outperform Start Price: $29.53 CEMP Score: -142.63

Antibiotic developments

Leaderboard

Find the members with the highest scoring picks in CEMP.

Score Leader

RonaldSpeth1

RonaldSpeth1 (59.25) Score: +281.92

The Score Leader is the player with the highest score across all their picks in CEMP.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
ta2122 37.08 2/8/2012 Underperform 5Y $6.05 -61.57% +111.79% +173.36 4 Comments
red1582 < 20 11/13/2012 Underperform 3M $6.00 -61.25% +106.36% +167.61 1 Comment
rknapton 84.36 8/7/2013 Underperform 5Y $9.25 -74.86% +68.29% +143.15 1 Comment
dasilook 33.91 10/26/2017 Outperform 5Y $2.28 +1.83% +11.35% -9.53 0 Comment
TMFTypeoh 93.94 10/23/2017 Outperform 5Y $2.73 -14.68% +10.82% -25.50 1 Comment
beecha < 20 8/29/2017 Outperform 5Y $2.65 -12.26% +17.14% -29.41 0 Comment
This player feels very strongly about this pick and has marked it a Top Pick. Top Picks do not affect a player’s score. MarkBiotech 34.30 10/18/2017 Outperform 5Y $2.90 -19.83% +11.31% -31.14 0 Comment
gunda7907 < 20 8/18/2017 Outperform 5Y $2.90 -19.83% +16.96% -36.78 0 Comment
Coolestnerdever 62.34 12/29/2016 Outperform 5Y $2.60 -10.58% +26.94% -37.52 0 Comment
Traced < 20 10/4/2017 Outperform 5Y $3.28 -29.01% +12.45% -41.46 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

Player Name Player
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
S&P
Gain
Score End Date Commentary
TrackRWBaird 87.62 12/12/2013 Outperform NS $12.95 -82.05% +59.39% -141.43 0 Comment
TrackStifel 90.56 3/15/2012 Outperform NS $7.74 -69.96% +103.20% -173.17 0 Comment
TrackNeedham 90.45 3/15/2012 Outperform NS $7.74 -69.96% +103.20% -173.17 0 Comment
trackwbbsecuriti < 20 2/13/2012 Outperform NS $6.11 -61.95% +110.41% -172.36 0 Comment

Advertisement